Written answers
Tuesday, 10 October 2017
Department of Health
Medicinal Products Reimbursement
Josepha Madigan (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source
302. To ask the Minister for Health his plans to expand the licence for pembrolizumab to cover rare cancers (details supplied). [42530/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments